Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
BörsenkürzelHLN
Name des UnternehmensHaleon PLC
IPO-datumJul 18, 2022
CEOMcnamara (Brian)
Anzahl der mitarbeiter- -
WertpapierartDepository Receipt
GeschäftsjahresendeJul 18
AddresseBuilding 5, First Floor
StadtWEYBRIDGE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlKT13 0NY
Telefon441932822000
Websitehttps://www.haleon.com/
BörsenkürzelHLN
IPO-datumJul 18, 2022
CEOMcnamara (Brian)
In den vergangenen 5 Jahren wurden insgesamt
570.00M
USD an Dividenden ausgeschüttet.
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023